AzTrials
AzTrials

Constipation - FunctionalNCT07340203

Cross-Cultural Adaptation, Validity, and Reliability of the Wexner Questionnaire in Patients With Constipation

An observational study of Constipation - Functional, run by Ahi Evran University Education and Research Hospital at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The investigators will conduct a validity and reliability study of the Wexner Constipation Questionnaire, used for constipation, in Turkish. For this purpose, investigators will administer the Wexner Questionnaire, translated from English to Turkish, and the accompanying Constipation Quality of Life Scale to 200… Read more about this study

Who is it for?
Ages 18 to 90 years
Conditions the study is for
Constipation - Functional
What is being tested?
survey
How many people
202 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Jul 2025to 13 Mar 2026
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 90 years
  • All sexes
  • Adult, Older adult

Study population: Men and women with chronic constipation

Who may be able to join

  • Being over 18 years of age
  • Being diagnosed with functional constipation according to Rome IV criteria
  • Having undergone an anorectal examination by a gastroenterologist
  • Having no history of neurodegenerative disease (e.g., multiple sclerosis, spinal cord injury, or stroke)
  • Having no history of metabolic disorders (e.g., diabetes, hypothyroidism, or hypercalcemia)
  • Having no history of opioid-induced constipation
Show all 10Show fewer
  • Having no history of irritable bowel syndrome
  • Having no history of congenital anorectal abnormality
  • Having no history of colon cancer or pregnancy
  • Having the ability to read and write Turkish.

Who cannot join

  • Not wanting to continue the study.
  • Having any complaints, such as anorectal bleeding, during the test-retest interval.

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Kirşehir Ahi Evran University Physical Therapy and Rehabilitation Hospital

    Kırşehir, Centre, 40000

Other trials in Turkey (Türkiye)

About this study

Official title: Cross-Cultural Adaptation, Validity, and Reliability of the Wexner Questionnaire

The investigators will conduct a validity and reliability study of the Wexner Constipation Questionnaire, used for constipation, in Turkish. For this purpose, investigators will administer the Wexner Questionnaire, translated from English to Turkish, and the accompanying Constipation Quality of Life Scale to 200 participants. Investigators will repeat the Wexner questionnaire for some participants after two weeks.

Read the detailed description

To assess the cultural adaptation, validity, and reliability of the eight-question Wexner Constipation Questionnaire, the questionnaire was first translated from English to Turkish, then back from Turkish to English, and finally back from English to Turkish. The questionnaire was finalized with the collaboration of an internal medicine specialist and a gastroenterologist to prepare the Turkish version. It will then be administered to a minimum of 200 participants, along with the Constipation Quality of Life Questionnaire, previously validated and reliable in Turkish and used for constipation. For reliability, the questionnaire will be repeated for a portion of the participants after two weeks.

Being tested
survey

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • surveyOther

    Also called questionnaire

    survey application

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Application of survey to participants

    First administration of the Wexner questionnaire to all participants

    Measured: Baseline (Day 1)

  2. Application of survey to participants

    First administration of the quality of life questionnaire to all participants

    Measured: Baseline (Day 1)

Secondary outcomes (2)
  1. Application of survey to participants

    Wexner questionnaire were administered to the participants a second time two weeks later.

    Measured: Baseline (Day 1)

  2. Application of survey to participants

    Quality of life questionnaire were administered to the participants a second time two weeks later.

    Measured: Baseline (Day 1)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Jan 2026
  2. Study start1 Jul 2025
  3. Primary completion12 Dec 2025
  4. Study completion13 Mar 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Prospective
Enrolment
202 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07340203
Sponsor's protocol ID
KAEU-EBAYRAMOGLUD-003
Status last verified
Sep 2026
First submitted
28 Oct 2025
Last updated
24 Sep 2026
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

An observational study of Constipation - Functional, run by Ahi Evran University Education and Research Hospital at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 10 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 24 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Application of survey to participants (time frame: Baseline (Day 1)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in